PAX ADVANCED THERAPIES / INVESTORS
Building the Future of
Regenerative Medicine
PAX is developing a regenerative immunology platform positioned at the intersection of:
01 / PLATFORM
A Platform at the Intersection of Science and Care
Biotechnology
Regenerative Medicine
Veterinary Healthcare
Cell Therapy
Translational Science
02 / INVESTABILITY
Why PAX
01
Significant Clinical Need
Orthopedic and inflammatory conditions remain major challenges across veterinary care.
02
Differentiated Technology
PBMC-focused concentration platform designed around biological healing mechanisms.
03
Platform Growth Potential
Applications across multiple treatment areas create opportunities for future growth.
04
Vision for Expansion
Veterinary medicine provides an initial pathway while supporting broader scientific advancement.
03 / OPPORTUNITY
Strategic Opportunities
We welcome discussions with:
